'Nanojackets' Could Change Cancer Care

"Nanojackets" Being Tested As Means To Deliver New Cancer Medications.

MedPage Today (8/20, Baum) reports, "A novel nanotechnology drug delivery system under development to infiltrate breast cancer tumors could pave the way for treating other diseases." Development is being led by Mark Kester, professor of pharmacology and director of the Penn State Center for NanoMedicine and Materials, who "explained that the team has developed nontoxic 'nanojackets' that use calcium phosphosilicate nanoparticles...to deliver the toxic siRNA safely to the gene mutation." He also "estimates it will take another 1-and-a-half years to get to the point where they will have enough data to submit an IND application," and "another five to eight years to get the technology to the point where it can be submitted for FDA approval."